Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis

• Published in: PloS one Vol. 10; no. 11; p. e0136908
• Main Authors: Migita, Kiyoshi, Komori, Atsumasa, Kozuru, Hideko, Jiuchi, Yuka, Nakamura, Minoru, Yasunami, Michio, Furukawa, Hiroshi, Abiru, Seigo, Yamasaki, Kazumi, Nagaoka, Shinya, Hashimoto, Satoru, Bekki, Shigemune, Kamitsukasa, Hiroshi, Nakamura, Yoko, Ohta, Hajime, Shimada, Masaaki, Takahashi, Hironao, Mita, Eiji, Hijioka, Taizo, Yamashita, Haruhiro, Kouno, Hiroshi, Nakamuta, Makoto, Ario, Keisuke, Muro, Toyokichi, Sakai, Hironori, Sugi, Kazuhiro, Nishimura, Hideo, Yoshizawa, Kaname, Sato, Takeaki, Naganuma, Atsushi, Komatsu, Tatsuji, Oohara, Yukio, Makita, Fujio, Tomizawa, Minoru, Yatsuhashi, Hiroshi
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 17-11-2015; Public Library of Science (PLoS)
• Subjects: Aberration; Adrenal Cortex Hormones - therapeutic use; Adult; Aged; Alanine; Alanine transaminase; Alternations; Apoptosis; Autoimmune diseases; Biomarkers; Biomarkers - blood; Biopsy; Cancer; Case-Control Studies; Cell cycle; Cirrhosis; Correlation; Female; Fibrosis; Hepatitis; Hepatitis C; Hepatitis C, Chronic - blood; Hepatitis, Autoimmune - blood; Hepatitis, Autoimmune - drug therapy; Humans; Inflammation; Liver; Liver cirrhosis; Liver diseases; Male; MicroRNAs; MicroRNAs - blood; Middle Aged; miRNA; Pathogenesis; Patients; Polymerase chain reaction; Ribonucleic acid; RNA; Serum levels; Japan
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0136908

Recent studies have demonstrated that micro (mi)RNA molecules can be detected in the circulation and can serve as potential biomarkers of various diseases. This study used microarray analysis to identify aberrantly expressed circulating miRNAs in patients with type 1 autoimmune hepatitis (AIH) compared with healthy controls. Patients with well-documented and untreated AIH were selected from the National Hospital Organization (NHO)-AIH-liver-network database. They underwent blood sampling and liver biopsy with inflammation grading and fibrosis staging before receiving treatment. To further confirm the microarray data, circulating expression levels of miR-21 and miR-122 were quantified by real-time quantitative polymerase chain reaction in 46 AIH patients, 40 patients with chronic hepatitis C (CHC), and 13 healthy controls. Consistent with the microarray data, serum levels of miR-21 were significantly elevated in AIH patients compared with CHC patients and healthy controls. miR-21 and miR-122 serum levels correlated with alanine aminotransferase levels. Circulating levels of miR-21 and miR-122 were significantly reduced in AIH patients with liver cirrhosis, and were inversely correlated with increased stages of fibrosis. By contrast, levels of circulating miR-21 showed a significant correlation with the histological grades of inflammation in AIH. We postulate that aberrantly expressed serum miRNAs are potential biomarkers of AIH and could be implicated in AIH pathogenesis. Alternations of miR-21 and miR-122 serum levels could reflect their putative roles in the mediation of inflammatory processes in AIH.